748
Views
4
CrossRef citations to date
0
Altmetric
State of the Art Reviews

The Relationship between Tumor Necrosis Factor-α Polymorphisms and Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis

, , , , , & show all
Pages 915-922 | Received 03 Mar 2011, Accepted 09 Jul 2010, Published online: 18 Aug 2011

REFERENCES

  • Sabahi A. Hepatitis C virus entry: The early steps in the viral replication cycle. Virol J. 2009;6:117.
  • Hoofnagle J. Hepatitis C: The clinical spectrum of disease. Hepatology. 1997;26:15S.
  • Sun J, Yu R, Zhu B, Wu J, Larsen S, Zhao W. Hepatitis C infection and related factors in hemodialysis patients in china: Systematic review and meta-analysis. Ren Fail. 2009;31:610–620.
  • Ken CH, Qian X, Zhen Y. Investigation of hepatitis C virus infection in chronic hemodialysis patients. J Cell Mol Immunol. 2001;17(5):448–449 [in Chinese].
  • Xiaonan Y, Li J, Weixin F, Hongfu G, Rongwei F. Study of hepatitis C virus infection in patients on hemodialysis. China Public Health. 2002;18(5):597–598 [in Chinese].
  • Perico N, Cattaneo D, Bikbov B, Remuzzi G. Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol. 2009;4(1):207–220.
  • McKenna O, Cunningham C, Blake C. Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: A cross-sectional survey. BMC Publ Health. 2009;9:323.
  • Omland LH, Farkas DK, Jepsen P, Obel N, Pedersen L. Hepatitis C virus infection and risk of cancer: A population-based cohort study. Clin Epidemiol. 2010;2:179–186.
  • Tilg H, Diehl AM. Cytokines in alcohlic and nonalcoholic steatohepatitis. N Engl J Med. 2000;343:1467.
  • Saito I, Miyamura T, Ohbayashi A, . Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA. 1990;87:6547–6549.
  • Di Bisceglie AM. Natural history of hepatitis C: Its impact in clinical management. Hepatology. 2000;31:1014–1018.
  • Rao V, Fabrizi F, Pennell P, . Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis population. Ren Fail. 2010;32(6):721–726.
  • Koziel MJ. The role of immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepat. 1997;2:31–41.
  • Fukuda R, Ishimura N, Ishihara S, . Intrahepatic expression of proinflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver. 1996;16:390–399.
  • Larrea E, Garcia N, Qian C, . Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology. 1996;23:210–217.
  • Hall CH, Kassel R, Tacke RS, Hahn YS. HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta. PLoS One. 2010;5(8):e12154.
  • Persico M, Capasso M, Persico E, Interleukin-10-1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol. 2006;45(6):779–785.
  • Palmer C, Corpuz T, Guirguis M, . The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection. Gut. 2010;59(3):397–404.
  • Pociot F, D’Alfonso S, Compasso S, . Functional analysis of a new polymorphism in the human TNF-α gene promoter. Scand J Immunol. 1995;42:501e4.
  • Wilson AG, di Giovine FS, Blakemore AI, Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1:353.
  • Constantini PK, Wawrzynowicz-Syczewska M, Clare M, Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: An investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy. Liver. 2002;22(5):404–412.
  • Xiao-rong M, Hong Y. Genetic association of tumor necrosis factor-alpha polymorphism with hepatits C virus infection. Clin Focus. 2007;22:6 [in Chinese].
  • Goyal A, Kazim SN, Sakhuja P, . Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol. 2004;72(1):60–65.
  • Zein NN, Germer JJ, El-Zayadi AR, . Ethnic differences in polymorphisms of tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in patients with chronic hepatitis C virus infection. Am J Trop Med Hyg. 2004;70(4):434–437.
  • Lio D, Caruso C, Di Stefano R, IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection. Hum Immunol. 2003;64(7):674–680.
  • Mangia A, Santoro R, Piattelli M, IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine. 2004;25(3):103–109.
  • Hohler T, Kruger A, Gerken G, . Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol. 1998;54(3):173–177.
  • Bahr MJ, el Menuawy M, Boeker KH, . Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C. Liver Int. 2003;23(6):420–425.
  • Wang Y, Kato N, Hoshida Y, Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology. 2003;37(1):65–71.
  • Rosen HR, McHutchison JG, Conrad AJ, . Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol. 2002;97(3):714–720.
  • Rosen HR, Miner C, Lewinsohn D, . Determination of hepatitis C virus-specific effector/memory CD4_T cell frequencies at different clinical stages of disease. Hepatology. 2002;35:190–198.
  • Schiemann U, Glas J, Torok P, . Response to combination therapy with interferon alfa-2a and ribavirin in chronic hepatitis C according to a TNF-alpha promoter polymorphism. Digestion. 2003;68(1):1–4.
  • Valenti L, Pulixi E, Fracanzani AL, . TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis. J Hepatol. 2005;43(6):944–950.
  • Kusumoto K, Uto H, Hayashi K, Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine. 2006;34(1–2):24–31.
  • Barrett S, Collins M, Kenny C, . Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol. 2003;71(2):212–218.
  • Pereira FA, Pinheiro da Silva NN, Rodart IF, Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol. 2008;80(1):58–64.
  • Yanjuan ZH, Lvtan L. Detection of hepatitis C virus marker in hemodialysis patients. Chin J Nephrol. 1997;13(5):283 [in Chinese].
  • Wang C, Sun J, Zhu B, . Hepatitis B virus infection and related factors in hemodialysis patients in China – Systematic review and meta-analysis. Ren Fail. 2010;32(10):1255–1264.
  • Mioli VA, Balestra E, Bibiano L, . Epidemiology of viral hepatitis in dialysis patients centers: A national survey. Nephron. 1992;61(3):278–283.
  • Fabrizi F, Lunghi G, Bacchini G, . Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients. Nephron Dial Transplant. 1997;12(8):1645–1651.
  • Xijie L, Liuqin L. Relationship between hemodialysis and viral hepatitis. J Nephrol Dialy Transplant. 1998;7(3):245–246 [in Chinese].
  • Xinyu ZH, Yulin G, Houyi W, Lvqi H. Infection of hepatitis B, C and G viruses in hemodialysis patients. J Clin Intern Med. 2001;18(3):214–216 [in Chinese].
  • Koziel MJ. Cytokines in viral hepatitis. Sem Liver Dis. 1999;19:157–169.
  • Takaki A, Wiese M, Maertens G, . Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000;6:578–582.
  • Knight JC, Udalova I, Hill AV, . A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet. 1999;22:145–150.
  • Chen Y, Pei J. An assessment of a TNF polymorphic marker for the risk of HCV infection: Meta-analysis and a new clinical study design. Infect Genet Evol. 2009;9(6):1356–1363.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.